Home / Pharmacy & pharmaceuticals / Micromedex

Merative L.P. (Ann Arbor, US)

Micromedex

Best-in-KLAS reference platform for hospital pharmacists and clinicians, active in 80+ countries. Combines drug information, interaction checks, toxicology (POISINDEX), IV compatibility and 700+ clinical calculators. Extended with AI search functionality in 2025.

Shared spot9of 16 professional tools with a GDPR profileOur summary of what the provider itself publishes about your data: whether the data is stored in the EU (2 points), whether there is a certification or GDPR guarantee (1), and whether the provider is established in the Netherlands or the EU (1). 3 or 4 points is Strong, 2 Good, 1 Limited, 0 Unknown. How we measure in pharmacy & pharmaceuticals
GDPR: Limited
  • Provider based outside the EU
  • Publishes certification/GDPR safeguards

Each tile is a professional tool in pharmacy & pharmaceuticals, with the strongest GDPR profile on the left. 6 professional tools, like Micromedex, have a limited profile: they share this spot. Click through to that tool.

Priceon request (hospitals/healthcare groups)enterprise licence on request (hospitals/healthcare groups)
Free trialYes
BasedAnn Arbor, USOutside EU
ModelNot publicAI search feature (since September 2025), underlying language model not public; processing outside the EEA/UK with standard contractual clauses; Merative: HITRUST, ISO 27001, 27017, 27018, 27701 and SOC 2 Type 2, not listed per product (according to provider); demo or trial access on request

Last checked: 28 October 2026 · How we check

Is this your tool? Fill in missing details

What it does

2,500+ drug monographs
Drug interaction checker
POISINDEX toxicology database
IV compatibility check
Drug identification and comparison
700+ clinical calculators
RED BOOK price data (360,000+ products)
Neonatal and paediatric information (NeoFax)

Comparable in pharmacy & pharmaceuticals

All 16 professional tools for pharmacy & pharmaceuticals

Micromedex compared

Underlying model

AI search feature (since September 2025), underlying language model not public; processing outside the EEA/UK with standard contractual clauses; Merative: HITRUST, ISO 27001, 27017, 27018, 27701 and SOC 2 Type 2, not listed per product (according to provider); demo or trial access on request. Many tools are built on a large model from, for example, OpenAI or Anthropic. If in doubt, ask for the data processing agreement: it states where your data goes.

GDPR check for pharmacy & pharmaceuticals
Which AI model does Micromedex use?
The maker of Micromedex does not publish which AI model is underneath. AI search feature (since September 2025), underlying language model not public; processing outside the EEA/UK with standard contractual clauses; Merative: HITRUST, ISO 27001, 27017, 27018, 27701 and SOC 2 Type 2, not listed per product (according to provider); demo or trial access on request.
How much does Micromedex cost?
enterprise licence on request (hospitals/care groups). Check the current price on the provider's website; rates change often.
Who is Micromedex for?
Micromedex is aimed at pharmacy & pharmaceuticals, healthcare. It fits work such as carrying out medication reviews and interaction checks, automating prescription processing and dispensing, and patient communication and guidance on medication use.
What should I look out for with AI in pharmacy & pharmaceuticals?
Medication data is special category personal data (GDPR). Only use systems with a data processing agreement and EU hosting; do not store audio recordings of pharmaceutical consultations unencrypted on external servers. AI-supported medication reviews and interaction checks are supportive, the pharmacist remains ultimately responsible for the pharmaceutical care and must never rely blindly on algorithmic outcomes.

Every Friday: what changed in AI for pharmacy & pharmaceuticals

New models, prices, oversight and tools, with sources and what it means for you. One email a week, unsubscribe with one click.

View a sample

We only use your address for this newsletter. You confirm first by email.